SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: 4-(4-Chlorophenyl)-1-[4-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]phenyl]-4-oxobutyl]piperidin-4-yl decanoate (as per EP & USP)
异名: Haloperidol Decanoate USP Related Compound I ; Haloperidol decanoate-4- piperidinol analog
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: CCCCCCCCCC(OC1(C2=CC=C(Cl)C=C2)CCN(CCCC(C3=CC=C(N4CCC(O)(C5=CC=C(Cl)C=C5)CC4)C=C3)=O)CC1)=O
Haloperidol Decanoate EP Impurity D is chemically 4-(4-Chlorophenyl)-1-[4-[4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]phenyl]-4-oxobutyl]piperidin-4-yl decanoate (as per EP & USP) . It is also known as Haloperidol Decanoate USP Related Compound I ; Haloperidol decanoate-4- piperidinol analog. Haloperidol Decanoate EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Haloperidol Decanoate EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Haloperidol Decanoate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Comparative bioavailability study of two haloperidol decanoate containing products
By van Weringh G; Komen B J; Thieme R E; van der Hoeven R T; Vos T
From Pharmacy world & science : PWS (1994), 16(6), 243-7.
Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects
By Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
From Acta psychiatrica Belgica (1983), 83(1), 57-68